<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Q13 Continuous Manufacturing of Drug Substances and Drug Products; International Council for Harmonisation; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Q13 Continuous Manufacturing of Drug Substances and Drug Products; International Council for Harmonisation; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2021-10-14 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or the Agency) is announcing the availability of a draft guidance for industry entitled "Q13 Continuous Manufacturing of Drug Substances and Drug Products." The draft guidance was prepared under the auspices of the International Council for Harmonisation (ICH), formerly the International Conference on Harmonisation. The draft guidance provides clarification on continuous manufacturing (CM) concepts and describes scientific approaches and regulatory considera...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2021-22451</p>
    <p><strong>Publication Date:</strong> 2021-10-14</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2021/10/14/2021-22451/q13-continuous-manufacturing-of-drug-substances-and-drug-products-international-council-for">https://www.federalregister.gov/documents/2021/10/14/2021-22451/q13-continuous-manufacturing-of-drug-substances-and-drug-products-international-council-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2021-22451</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
